Drug Topics

OCTOBER 27, 2024

A second immunization session focused on updates in meningococcal disease, HPV, and Mpox.

Immunization 196

Immunization 196

Fierce Healthcare

OCTOBER 27, 2024

Fierce Healthcare reporters returned from Las Vegas on Wednesday after four days packed with meetings, interviews and on-stage conversations all focused on healthcare innovation. | From AI (of course) to PBMs to women's health, here are some topics that got our attention at HLTH 2024.

140

140

Drug Topics

OCTOBER 27, 2024

PBM reform legislation has progressed further in Congress than ever before.

186

186

STAT

OCTOBER 27, 2024

Every day, my inbox bursts with opinions about everything from poop transplants to climate change. When news in medicine happens, someone will inevitably email me offering an op-ed. Except on one topic: the health of the major presidential candidates. Almost no one wants to touch it.

134

134

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patient Care

Drug Topics

OCTOBER 27, 2024

A conversation with Lauren Angelo, PharmD, MBA, associate dean of academic affairs and associate professor of pharmacy practice at Rosalind Franklin University of Medicine and Science College of Pharmacy.

Vaccines 182

Vaccines 182

STAT

OCTOBER 27, 2024

Here’s the paradox: The most influential set of rules for the foods we eat are the ones most of us ignore. But they still matter for millions of  Americans. The Dietary Guidelines for Americans, reviewed and issued by the federal government every five years, have broad impact on what goes into federal nutritional assistance programs, from WIC for women and young children to school lunches to meals for veterans or seniors.

133

133

Pharmacy Times

OCTOBER 27, 2024

Nearly 19,000 independent pharmacies continue to work across the country, with more than 200,000 employees and millions of patients.

Independent Pharmacies 107

Independent Pharmacies 107

Drug Topics

OCTOBER 27, 2024

Making the store’s front end a priority can increase revenue opportunities and boost pharmacy profit.

119

119

Med Ed 101

OCTOBER 27, 2024

One of the last hurdles in becoming a licensed pharmacist is the North American Pharmacist Licensure Examination (NAPLEX). NABP recently released information on what to expect for those taking the NAPLEX exam on or after May 1st, 2025. There are some significant changes to the content outline and I outline those changes in the Youtube […] The post NAPLEX Changes in 2025: What Pharmacists Need to Know appeared first on Med Ed 101.

105

105

Drug Topics

OCTOBER 27, 2024

The digest was released at the NCPA 2024 Annual Convention and Expo.

Independent Pharmacies 98

Independent Pharmacies 98

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

The FDA Law Blog

OCTOBER 27, 2024

By Deborah L. Livornese & John W.M. Claud & Charles D. Snow — On October 21, 2024, the Alliance for Natural Health USA (“ANH”), and Meditrend Inc., a homeopathic drug company, filed a complaint on behalf of the homeopathic drug industry against FDA in the District Court for the District of Columbia (“D.D.C.”). This lawsuit presents an interesting reading of the statute at issue, one that is diametrically opposed to that of FDA.

FDA 100

FDA 100

Drug Topics

OCTOBER 27, 2024

In case you missed it, this week we had stories about the FDA approval of Pfizer's RSV vaccine, vaccines and COVID-19 hospitalization in children, race-based disparities in multimodal analgesia, and more.

Vaccines 76

Vaccines Hospitals FDA 76

Therapeutics Education Collaboration

OCTOBER 27, 2024

In episode 589, Mike and James invite Jennifer Young back to the podcast again to talk about a topic that Mike absolutely loves – Vitamin D for everyone. Tune in to hear about all the latest, and the older, evidence. Do you agree we should remove the question mark from the podcast title? Show notes 1) Tools for Practice Vitamin D and Fracture Prevention: Not what it’s cracked up to be?

45

45

BioPharm

OCTOBER 27, 2024

Phenotypic screening is a vital tool in drug discovery, enabling scientists to rapidly identify potential drugs early in the discovery pipeline. Kinetic information gained by repeated image acquisition within a physiologically relevant environment provides insight into the dynamic changes which are often overlooked using end-point analysis alone.

40

40

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

STAT

OCTOBER 27, 2024

During an annual checkup, the patient says: “Doc, I saw a commercial about a blood test that can tell if I’ll develop Alzheimer’s. I watched my mother go through it. I want to get tested.” He’s referring to the new Alzheimer’s blood-based biomarkers. Despite not showing any symptoms of Alzheimer’s — he manages his own finances, drives, shops, and cooks elaborate meals for his wife — he’s clearly worried.

129

129

BioPharm

OCTOBER 27, 2024

Scaling up the production of viral vectors, particularly adeno-associated virus (AAV), remains wrought with challenges. The issues of low titer and yield, and vector degradation such as unfolding, aggregation and oxidation, need to be better understood and managed by carefully optimizing buffer, pH and excipients. This article addresses key advancements at each step in the workflow — from maximizing titer output at scale upstream to optimized formulation compositions at fill/finish — to support

40

40

Fuld

OCTOBER 27, 2024

In this episode we tackle a crucial topic at the heart of the energy transition: Incumbents vs Disruptors. As the push toward net zero gains momentum, and more companies transition to EVs, traditional energy giants and innovative newcomers are competing to shape the future energy landscape. The question is, how will these dynamics influence the path to sustainability and who will take the lead?

52

52

BioPharm

OCTOBER 27, 2024

In the rapidly evolving world of cell and gene therapies, innovation is essential if we want to revolutionize medicine. Collaboration in the early stages of development allows us to optimize workflows and apply rigorous quality standards, moving therapies forward without regulatory delays. Our innovative aseptic fluid transfer technologies improve process quality and reduce contamination risks.

40

40

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

BioPharm

OCTOBER 27, 2024

Examine the dynamic changes in cell morphology which occur when cells undergo ferroptosis and investigate label-free and fluorescence-based methods of kinetic quantification.

Labelling 40

Labelling 40

BioPharm

OCTOBER 27, 2024

As the FDA signals stronger support for advancing gene therapy approvals, manufacturers face increasing pressure to get to market quickly while maintaining viral vector quality. This article tackles emerging scale-up challenges to efficiency and safety, with an in-depth look at strategies to optimize viral vector production, manage costs, and collaborate on industry standardization and automation.

FDA 40

FDA 40

BioPharm

OCTOBER 27, 2024

The response of tumor cells, such as glioblastomas, to cytotoxic chemotherapeutic compounds is a complex and dynamic process that is crucial to understand in neurooncology research. Using pre-trained neural networks to accurately segment individual cells and classify them as live or dead is a powerful, robust approach for assessing cytotoxicity in glial cell types.

Labelling 40

Labelling Compounding 40

BioPharm

OCTOBER 27, 2024

Live-cell imaging enables acquisition of phase contrast images and provides an ideal platform to study multi-faceted biological paradigms in drug discovery. This is vital to our understanding of human diseases and treatment strategies. The movement of these models towards increasingly complex physiologically relevant ones, including patient-derived cells and induced pluripotent stem cells (iPSCs), has concurrently driven the need for label-free methods that are non-perturbing to deliver deeper b

Labelling 40

Labelling 40

BioPharm

OCTOBER 27, 2024

Elemental impurity testing is essential to deliver safe drug products to patients and is a regulatory requirement. It is important to assess the risk of elemental impurities from all sources in the manufacturing process, including process equipment, water, container/packaging, raw materials, drug substances, and the final drug product.

Packaging 40

Packaging 40

BioPharm

OCTOBER 27, 2024

The nexus between biopharmaceuticals and sustainability is seemingly far apart, however, it is increasingly recognized as an inevitable challenge. It is encouraged to take a sustainable approach to reducing the environmental impact of the production and supply of medicines while improving people's health; delivering the well-being of people and the planet.

40

40

BioPharm

OCTOBER 27, 2024

Compendial testing covers a wide array of materials, subjects, and locations designed to create standards and programs that ensure the quality and safety of approved articles for a geographical location or areas such as USP (For the United States market) or Ph Eur (For European markets). The compendia provide monographs and test methods for active ingredients, raw materials, drug products, utilities (water and gases), and packaging components.

Packaging 40

Packaging 40

BioPharm

OCTOBER 27, 2024

The nexus between biopharmaceuticals and sustainability is seemingly far apart, however, it is increasingly recognized as an inevitable challenge. It is encouraged to take a sustainable approach to reducing the environmental impact of the production and supply of medicines while improving people's health; delivering the well-being of people and the planet.

40

40

BioPharm

OCTOBER 27, 2024

This whitepaper explores the importance of safe cGMP pharma product storage, highlighting challenges CDMOs face with inventory bottlenecks and delays. It examines off-site cGMP storage benefits, including cost savings, flexibility, and compliance, while addressing key factors for maintaining product safety and accessibility.

40

40

BioPharm

OCTOBER 27, 2024

The nexus between biopharmaceuticals and sustainability is seemingly far apart, however, it is increasingly recognized as an inevitable challenge. It is encouraged to take a sustainable approach to reducing the environmental impact of the production and supply of medicines while improving people's health; delivering the well-being of people and the planet.

52

52